MREO Stock Analysis: Buy, Sell, or Hold?
MREO - Mereo BioPharma Group plc American Depositary Shares
$0.33
0.00 (0.00%)
▲
5d:
-5.66%
30d:
-19.51%
90d:
-10.93%
HOLD
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When MREO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MREO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MREO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MREO is currently trading at $0.33, which is considered oversold relative to its 30-day fair value range of $0.34 to $0.40.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.73 (+424.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.73 (+424.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.34 -
$0.40
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 424.8% below Wall St target ($1.73)
- CAUTION: Recommendation downgraded due to -5.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.34 -
$0.40
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.31
Resistance Level
$0.37
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.07
Wall Street Target
$1.73
(+424.8%)
Share & Embed Analysis
Last updated: April 02, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MREO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 61 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 48 HOLD |
